NiKem Research is the ideal partner for all for your drug discovery needs. Our Drug Discovery Services include:
Latest News (January 2012)
Dualsystems Biotech and NiKem Research are pleased to announce the formation of a strategic alliance
to jointly offer their respective drug/target profiling and drug discovery services NiKem Research announces establishment of a P450 3A4 induction assay- click here for more information NiKem Research and Chiesi Farmaceutici extend research collaboration- click here For our latest Catalogue, including our expanded ADMET/PK services and standalone Biochemical/in vitro Pharmacology, in vivo PD and MS MALDI TOF/TOF imaging services, please click here
A Complete Solution For Your Drug Discovery Needs
NiKem Research taking on your research challenges
Our mission is to help our clients and partners rapidly translate their discovery biology output into high quality preclinical candidates.
Why work with NiKem Research?
With our big pharma experience operating at biotech speed and our broad drug discovery capabilities, from hit generation to preclinical candidates, NiKem Research is a natural partner to support, simplify and accelerate your drug discovery research. Our track record of intellectual input, probem solving and success, our continually upgraded technologies and our focus on team work and communication, coupled with flexible business models ensure maximum delivery and maximum added value.
To learn more about how NiKem can help your company advance its pipeline and to take advantage of our free consultations please contact info@nikemresearch.com.
- To see a copy of our most recent newsletter, please click here
- Visit our resources for visitors to hear a recording of an account of our work discovering ORL-1 antagonists alongside a range of other valuable information to help you with your work- click here
- An interview on drug discovery outsourcing
with NiKem CEO Giuseppe Giardina